$BNTX.O #BIONTECH BIONTECH: iNeST update marks platform potential in the early lines of treatment | BUY | USD50 vs. 45: BIONTECH - BUY | USD50 vs. 45 iNeST update marks platform potential in the early lines of treatment BNT122 shows… https://t.co/p5v9iGQH9L #equity #stocks https://t.co/G1YqaNUyYi